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Fas is highly expressed in activated and germinal
center (GC) B cells but can potentially be inactivated
by misguided somatic hypermutation. We employed
conditional Fas-deficient mice to investigate the
physiological functions of Fas in various B cell sub-
sets. B cell-specific Fas-deficient mice developed
fatal lymphoproliferation due to activation of B cells
and T cells. Ablation of Fas specifically in GC B cells
reproduced the phenotype, indicating that the
lymphoproliferation initiates in the GC environment.
B cell-specific Fas-deficientmice also showed an ac-
cumulation of IgG1+ memory B cells expressing high
amounts of CD80 and the expansion of CD28-ex-
pressing CD4+ Th cells. Blocking T cell-B cell interac-
tion and GC formation completely prevented the fatal
lymphoproliferation. Thus, Fas-mediated selection
of GC B cells and the resulting memory B cell com-
partment is essential for maintaining the homeosta-
sis of both T and B lymphocytes.
INTRODUCTION
The Fas (CD95, Apo-1) receptor induces apoptosis upon en-
gagement by Fas ligand (FasL) and is critical for maintaining ho-
meostasis in the peripheral lymphoid organs (Krammer, 1999,
2000). Fas-deficient lpr mice and FasL-deficient gld mice de-
velop lymphadenopathy, splenomegaly, and a lupus-like auto-
immune disease characterized by autoantibody production
and the accumulation of abnormal Thy1+B220+CD4CD8 dou-
ble negative (DN) T cells (Takahashi et al., 1994; Watanabe-
Fukunaga et al., 1992). In humans, Fas mutations result in an
autoimmune lymphoproliferative syndrome (ALPS; Fisher et al.,
1995; Rieux-Laucat et al., 1995) that resembles the disease in
lpr and gld mice. B cells are thought to be critical drivers of
ALPS because, in lpr mice, ablation of B cells or restoration of
B cell Fas expression mostly prevents the autoimmune disease
(Shlomchik et al., 1994) (Fukuyama et al., 2002). Thus, Fasdeficiency in T cells is not sufficient for ALPS, and the interaction
between T and B cells is required for the full-blown disorder.
A T cell stimulated by the binding of antigen to its T cell recep-
tor (TCR) cannot become fully activated until it interacts with cos-
timulatory molecules expressed by the antigen-presenting cell
(APC) (Carreno and Collins, 2002). When this APC is a B cell,
T cell-B cell interaction occurs during which intercellular con-
tacts are formed to promote and regulate the activation, differen-
tiation, and effector functions of T cells. The binding of CD28
expressed on activated T cells to CD80 and/or CD86 on acti-
vated B cells delivers a powerful costimulatory signal to the
T cells (Lenschow et al., 1996; Linsley and Ledbetter, 1993). Ad-
ditional T cell costimulation is mediated by the binding of induc-
ible costimulator (ICOS), which is induced on T cells after activa-
tion (Hutloff et al., 1999). ICOS binds to ICOS ligand (ICOSL)
constitutively expressed on B cells (Yoshinaga et al., 1999).
During a primary humoral response, T cell-B cell interactions
through costimulatory molecules are also required for germinal
center (GC) formation and the GC reaction (Carreno and Collins,
2002). T cell dependent (Td) antigen-activated B cells enter the
primary follicle and form a GC where B cell expansion, somatic
hypermutation, affinity maturation, and differentiation into anti-
body-secreting plasma cells and memory B cells take place
(Rajewsky, 1996). Within the GC, only B cells with high affinity
for the cognate antigen interact with CD4+ T helper (Th) cells spe-
cific for the same antigen and thus are selected for differentiation
into either memory B cells or plasma cells. Memory B cells be-
come potent APCs with upregulated CD80 and CD86 expression
and thus induce rapid activation and expansion of the Th cell
population (Liu et al., 1995; Rajewsky, 1996). These activated
Th cells in turn drive the accelerated generation of plasma cells
and memory B cells that mediate a rapid and robust secondary
antibody response.
The GC reaction also involves the negative selection of GC
B cells with either suboptimal affinity for the cognate antigen or
affinity for a self-antigen (autoreactive). Fas-FasL interaction
has been implicated in this negative selection because, in trans-
genic mice, Fas-expressing autoreactive B cells are eliminated
upon interaction with FasL+ CD4+ T cells (Rathmell et al.,
1995). However, although GC B cells express high amounts of
Fas and are susceptible to Fas-mediated apoptosis in vitroImmunity 29, 615–627, October 17, 2008 ª2008 Elsevier Inc. 615
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B cells in immune responses to Td antigen is controversial. Smith
et al. (1995) showed that the GC reaction and memory B cell gen-
eration were normal in immunized lpr mice. However, Takahashi
et al. (2001) demonstrated that the selection of GC B cells and
the resulting memory B cell repertoire were abnormal in immu-
nized lpr mice. These and other studies show that much remains
unclear about the role of Fas-mediated cell death in controlling
the memory B cell repertoire in vivo.
It has not been possible to use lpr mice to clarify Fas functions
in B cells because these mutants lack Fas in all tissues and have
a distorted immune system dominated by the peculiar DN T cells
(Cohen and Eisenberg, 1991). It is not known whether the drastic
expansion of DN T cells affects the GC reaction in lpr mice. We
decided to build on our previous studies of conditional Fas-defi-
cient mice (Hao et al., 2004) and analyzed two strains of B cell-
specific Fas-deficient mice: one in which the Fas gene was ab-
lated in all B cell developmental stages and another in which
Fas was deleted only in GC B cells and in the memory B cells
and plasma cells derived from them. Of note, Fas expression
was intact in T cells of both strains. We show that Fas-mediated
apoptosis in GC B cells and the resulting memory B cell popula-
tion were essential for the homeostasis of both T and B cells.
RESULTS
Ablation of Fas Specifically in B Cells Leads to Fatal
Lymphocyte Infiltration
To ablate Fas specifically in B cells, we crossed Fasfl/fl mice, in
which the Fas gene is flanked by two loxP sites (Hao et al.,
2004), to Cd19-Cre mice to yield Fasfl/flCd19-Cre mice on the
C57Bl/6 genetic background. At both the DNA and protein
levels, the efficiency of Fas deletion in B cells of Fasfl/flCd19-
Cre mice was >80% (Figure 1A). Monitoring of a cohort of aging
Fasfl/flCd19-Cremice together with their control Fasfl/fl and Fasfl/+
Cd19-Cre littermates revealed that mutant mice of age >6
months were often smaller than controls and appeared to be
weak. A few mutants had skin lesions around the neck or ears
(data not shown). Approximately 80% of Fasfl/flCd19-Cre mice
died between 7 and 17 months of age, whereas all control
mice survived the 18 month observation period (Figure 1B).
The death of the mutants most likely arose from a lymphoprolifer-
ative disorder that usually became obvious at age >10 months
and manifested as splenomegaly and lymphoadenopathy (data
not shown). However, unlike lpr mice, there was no expansion
of the unusual DN T cell subset in Fasfl/flCd19-Cre mice
(Figure S1A available online).
Lpr mice die of kidney failure caused by massive autoantibody
production leading to immune-complex deposition in the kidney
(Cohen and Eisenberg, 1991). The amounts of serum IgM and
IgG autoantibodies were greater in Fasfl/flCd19-Cre mice com-
pared to those in Fasfl/fl controls but were still several folds lower
than amounts in Fasdel/del mice in which Fas is inactivated ubiq-
uitously (Figure S1B). This elevation in autoantibody titers paral-
leled a general trend in the mutants toward increased serum
antibody concentrations (Figure S1C). To ascertain the cause
of death of Fasfl/flCd19-Cre mice, we performed histopathologic
analyses of the liver, lungs, and kidneys. No abnormalities were
observed in these organs in 2-month-old Fasfl/flCd19-Cre mice616 Immunity 29, 615–627, October 17, 2008 ª2008 Elsevier Inc.(data not shown). However, in 6- and 14-month-old mutants,
there were dramatic infiltrations of mononuclear cells in the liver
and lungs (Figure 1C). Although there was negligible infiltration in
the mutant kidney at age 6 months, infiltrates were clearly pres-
ent at 14 months. Immunohistochemical staining showed that
these infiltrates were composed of a mixture of T and B cells
(data not shown). Further analysis of Fasfl/flCd19-Cre liver re-
vealed that the accumulating lymphocytes took the form of
multifocal periportal infiltrates that invaded and destroyed the
liver parenchyma (Figure 1C). Similarly, Fasfl/flCd19-Cre lung
displayed interstitial perivascular T and B cell infiltrates, and
Fasfl/flCd19-Cre kidney showed focal interstitial and periglomer-
ular infiltrates (Figure 1C). Abnormal lymphocyte infiltrates were
not seen in the pancreas, stomach, brain, or heart (data not
shown). Lymphocytes were rare in the nonlymphoid organs of
control mice (Figure 1C). Thus, Fasfl/flCd19-Cre mice die of mul-
tiple organ failure caused by massive lymphocyte infiltration and
inflammatory tissue destruction.
Activation and Hyperproliferation of Fas-Deficient B
Cells and Fas-Sufficient T Cells
B cell development in the bone marrow (BM) and spleen of 2- to
3-month-old Fasfl/flCd19-Cre mice was comparable to that in
Fasfl/fl controls (Supplemental Results and Figure S2). However,
flow-cytometric analysis of the cells present in the enlarged
lymphoid organs of Fasfl/flCd19-Cre mice showed that the total
lymphocyte number in Fasfl/flCd19-Cre spleen (187.3 ± 74.7 3
106) was increased by 2-fold compared that in control spleen
(91.1 ± 14.4 3 106) at 6–7 months (Figure 2A; p < 0.05). As ex-
pected, B cells were increased in number in Fasfl/flCd19-Cre
spleen compared to controls (95 ± 37.2 3 106 versus 53.7 ±
5.47 3 106), although this difference was not statistically signifi-
cant (p = 0.065). Unexpectedly, we also observed a 3-fold ex-
pansion in the total number of T cells of Fasfl/flCd19-Cre spleen
compared to that of controls (62.3 ± 20.9 3 106 versus 22.2 ±
4.07 3 106; p < 0.05).
To determine the activation status of the accumulating lym-
phocytes, we examined various molecules known to be impor-
tant for B or T cell activation. Unstimulated B cells and T cells
from Fasfl/flCd19-Cre mice showed control amounts of the
expression of CD40, and of CTLA-4 and FasL, respectively
(Figure S3 and data not shown). Moreover, the level of CD40 up-
regulation on Fas-deficient B cells in response to anti-IgM stim-
ulation was comparable to that of the control (Figure S3A). Sim-
ilarly, anti-CD3-stimulated T cells from Fasfl/flCd19-Cre mice
upregulated CD40L, CTLA-4, and FasL to amounts seen in con-
trols (Figures S3B–S3D). However, we found that CD28, a mole-
cule that is constitutively expressed on unstimulated CD4+ T
cells appeared to be slightly upregulated on CD4+ T cells
from 6- and 14-month-old Fasfl/flCd19-Cre mice compared to
controls (Figure 2Bi). ICOS was already slightly upregulated on
unstimulated T cells of 2-month-old mutant mice and was in-
creased significantly compared to controls at 6 and 14 months
(Figure 2Bii; p < 0.005). There was no difference in the amounts
of ICOSL expressed on B cells from 2-, 6-, or 14-month-old
Fasfl/fl or Fasfl/flCd19-Cre mice (Figure 2Biii). Intriguingly, B cells
from 6- and 14-month-old Fasfl/flCd19-Cre mice expressed
MHC class II more abundantly than did control B cells
(Figure 2Biv; p < 0.005), implying that Fas-deficient B cells
Immunity
Fas/ B Cells Cause Fatal LymphoproliferationFigure 1. Fasfl/flCd19-Cre Mice Die Prematurely Because of Lymphocyte Infiltration in Multiple Organs
(A) Confirmation of Fas deletion. The left side shows a representative Southern blot of naive FASFL/fl and Fasfl/flCd19-Cre B cells showing deletion of the Fas gene
in 83% of the latter (87.3% ± 4%, n = 4). The right side shows a representative flow-cytometric analysis of Fasfl/+Cd19-Cre and Fasfl/flCd19-Cre B cells (stimulated
for 2–4 days with LPS) showing that Fas protein expression was lacking in 81% of the mutant cells (85.4% ± 4.8%, n = 4).
(B) Reduced life span. Kaplan-Meier survival curves of Fasfl/flCd19-Cre mice compared to controls.
(C) Organ infiltration. Focal interstitial lymphocyte accumulation is shown in H&E-stained sections of livers, lungs, and kidneys of Fasfl/fl and Fasfl/flCd19-Cre mice
at the ages of 6 and 14 months. Scale bars apply to all panels in a row.have increased APC capacity. Thus, the lymphocytes that accu-
mulate in aged Fasfl/flCd19-Cre mice are activated.
To determine whether the lymphocyte accumulation in the
mutants was due at least in part to hyperproliferation, we fed
aged Fasfl/fl and Fasfl/flCd19-Cre mice BrdU-containing drinking
water and assessed BrdU incorporation in vivo. BrdU incorpora-
tion was observed in 3-4-fold more B cells and CD4+ and CD8+
T cells from the mutant mice compared to controls (Figure 2C).
Thus, the fatal lymphoproliferation in Fasfl/flCd19-Cre mice isdue to the activation and hyperproliferation of both T and
B cells.
Disrupted Lymphoid Architecture in Aged
Fasfl/flCd19-Cre Mice
We next analyzed lymphoid-organ architecture in Fasfl/flCd19-
Cre mice. At age 2 or 6 months, the mutants showed normal
spleen and LN structures (data not shown). At age 14 months,
hematoxylin-eosin (H&E) and immunohistochemical staining ofImmunity 29, 615–627, October 17, 2008 ª2008 Elsevier Inc. 617
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Fas/ B Cells Cause Fatal LymphoproliferationFigure 2. Hyperproliferation and Activation of T and B Cells and Disrupted Lymphoid-Organ Architecture in Fasfl/flCd19-Cre Mice
(A) Increased cell numbers. Absolute numbers of total lymphocytes, B cells, and T cells in spleens of Fasfl/fl and Fasfl/flCd19-Cre mice at age 6–7 months (n = 3/
genotype). For all figures, *p < 0.05 and **p < 0.005.
(B) Altered surface marker expression. CD4+ T cells, total T cells, and total B cells from Fasfl/fl and Fasfl/flCd19-Cre mice at the ages of 2, 6, or 14 months were
examined by flow cytometry for expression of CD28, ICOS, ICOSL, and MHCII as indicated.
(C) Increased proliferation. BrdU incorporation by B220+IgM+B cells and CD4+ and CD8+ T cells was measured by flow cytometry. The percentage of BrdU+ cells
is indicated.
(D and E) Sections of spleen (D) and LN (E) from 14-month-old Fasfl/fl and Fasfl/flCd19-Cre mice were stained with H&E (top and middle) or with immunohisto-
chemical staining for detection of T and B cells (bottom). T cells that were stained positively with anti-CD3 were dark blue in color, whereas B cells that were
stained positively with B220 antibody were brown. Scale bars apply to control and mutant samples in a pair.618 Immunity 29, 615–627, October 17, 2008 ª2008 Elsevier Inc.
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Fas/ B Cells Cause Fatal LymphoproliferationFigure 3. Increased Cytokine Production in Fasfl/flCd19-Cre Mice
(A) Elevated serum cytokines. Serum amounts of IFN-g, TNF-a, IL-10, and IL-6 were determined in Fasfl/fl and Fasfl/flCd19-Cre mice of ageR11 months. Results
shown represent the mean cytokine level ± SD (n = 4–6 mice/genotype).
(B) Increased numbers of cytokine-producing cells. Cells from LNs of aged Fasfl/fl and Fasfl/flCd19-Cre mice were fixed with 1.6% PFA, subjected to intracellular
staining with antibodies recognizing the indicated cytokine, and analyzed by flow cytometry. Numbers are the percentage of cells in the gated lymphocyte pop-
ulation that produced the indicated cytokine (n = 3–4).control spleens confirmed that both T and B cells were normally
localized in the periarteriolar lymphoid sheath (PALS) and the
B cell corona, respectively (Figures 2Di, 2Diii, and 2Dv). In con-
trast, T and B cells were mixed together in the mutant white
pulp (Figures 2Dii, 2Div, and 2Dvi). Similarly, T and B cells in con-
trol LNs were normally localized in the paracortical area and lym-
phoid follicles, respectively (Figures 2Ei, 2Eiii, and 2Ev), whereas
T and B cells were totally mixed in the mutant LN (Figures 2Eii,
2Eiv, and 2Evi). Higher magnification of these stained spleen
and LN sections showed that, compared to controls, lympho-
cytes in the mutants were large and had abundant cytoplasm
(Figures 2Diii, 2Div, 2Eiii, and 2Eiv). This age-dependent disruption
of lymphoid architecture is consistent with the abnormal lympho-
cyte activation and expansion observed in these mutants.Cytokine Elevation and Abnormal Differentiation
from Fasfl/flCd19-Cre Mice
The elevated expression of ICOS on T cells from Fasfl/flCd19-Cre
mice indicated that these cells were activated. To determine
whether cytokine production by these cells might be contributing
to the death of the mutant mice, we examined serum cytokines in
Fasfl/fl and Fasfl/flCd19-Cre mice. Amounts of IFN-g, TNF-a,
IL-10, and IL-6 were elevated in the mutant serum by an esti-
mated 3-fold (2783 ± 439 ng/ml versus 1043 ± 565 ng/ml;
p < 0.005), 7-fold (53.5 ± 42.5 ng/ml versus 7 ± 5.1 ng/ml; p <
0.05), 70-fold (1099 ± 720 ng/ml versus 16.5 ± 17 ng/ml; p <
0.005), and 20-fold (1099 ± 719.5 ng/ml versus 46.3 ± 35.8 ng/ml;
p < 0.05), respectively (Figure 3A). No differences in serum
amounts of IL-1a, IL-1b, IL-2, IL-4, IL-12, IL-13, IL-17, MIP-2, orImmunity 29, 615–627, October 17, 2008 ª2008 Elsevier Inc. 619
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Fas/ B Cells Cause Fatal LymphoproliferationTGF-b were detected (data not shown). Consistent with these
findings, more IFN-g-producing CD4+ T cells (1.1% ± 0.44% ver-
sus 0.19% ± 0.08%; p < 0.05) and IL-6-producing B220+ cells
(4.2% ± 2.1% versus 0.32% ± 0.38%; p < 0.05) were found in
the lymphoid organs of Fasfl/flCd19-Cre mice compared to those
of controls (Figure 3B). IL-10-producing CD4+ T cells were also
slightly (but not significantly) increased (2.85% ± 1.97% versus
0.59% ± 0.18%; p > 0.05). Numbers of TNF-a-producing T and
B cells were not increased at all (data not shown), suggesting
that other cell types are responsible for the elevated TNF-a pro-
duction in Fasfl/flCd19-Cre mice.
To investigate whether the altered cytokine production in the
mutant correlated with abnormal Th1 and Th2 cell differentiation,
we tested whether Fasfl/flCd19-Cre CD4+ T cells could differen-
tiate normally in vitro. Under Th1 cell-differentiation conditions,
approximately 3-fold more IFN-g- or TNF-a-producing cells
arose from Fasfl/flCd19-Cre CD4+ T cells than from controls
(Figure S4A, left). Under Th2 cell differentiation conditions, a sim-
ilar percentage of control and Fasfl/flCd19-Cre CD4+ T cells pro-
duced IL-4, whereas an increased percentage of Fasfl/flCd19-
Cre CD4+ T cells produced IL-10 compared to controls (51%
versus 30%) (Figure S4A, middle). More IFN-g-, TNF-a-, and
IL-10-producing cells were also observed when T cells from
Fasfl/flCd19-Cre mice were stimulated with PMA plus ionomycin
(data not shown). However, there was no increase in the percent-
age of IL-17-producing cells generated when Fasfl/flCd19-Cre
T cells were cultured under Th17 cell-differentiation conditions
(Figure S4A, right).
Taken together, these results show that a deficiency of Fas in
B cells has profound effects not only on serum-cytokine amounts
but also on T cell differentiation.
Abnormal Signaling of TCells from Fasfl/flCd19-CreMice
We next examined intracellular signaling in T cells from Fasfl/fl
Cd19-Cre mice. STAT1 is phosphorylated in wild-type (WT)
T and B cells in response to IFN-g (Pestka et al., 2004). Upon
in vitro IFN-g treatment, CD4+ and CD8+ T cells of Fasfl/flCd19-
Cre mice showed an age-dependent decrease in STAT1
(pY701) phosphorylation (Figure S4B). In contrast, IFN-g-in-
duced STAT1 phosphorylation was normal in B cells of Fasfl/fl
Cd19-Cre mice. STAT3 is phosphorylated in WT T and B cells
in response to IL-10 (Riley et al., 1999). However, CD4+ and
CD8+ T cells from Fasfl/fl mice did not respond well to IL-10 as
shown by their poor phosphorylation of STAT3 (pY705)
(Figure S4C, top). CD4+ and CD8+ T cells from Fasfl/flCd19-Cre
mice showed an age-dependent increase in STAT3 phosphory-
lation in response to IL-10 (Figure S4C, bottom). In contrast,
STAT3 phosphorylation in Fasfl/flCd19-Cre B cells in response
to IL-10 was comparable to that in controls at all three ages
examined.
IL-10 is known to inhibit IFN-g production by Th1 cells
(Moore et al., 1990). To determine whether the elevated serum
IL-10 in Fasfl/flCd19-Cre mice might be inhibiting the function of
their Th1 cells, we cultured control and mutant in vitro-differen-
tiated Th1 cells in mrIL-10 for 40 hr, restimulated them for 16 hr
with anti-CD3, and identified IFN-g-producing cells by intracel-
lular staining. Flow-cytometric analyses showed that a culture
in IL-10 reduced the percentage of mutant Th1 cells that
were able to produce IFN-g (56.1% ± 3.8%/ 39.5% ± 3.8%;620 Immunity 29, 615–627, October 17, 2008 ª2008 Elsevier Inc.p < 0.005), whereas the ability of control Th1 cells to produce
IFN-g was not significantly affected (Figure S5A). Thus, ele-
vated IL-10 inhibits the functionality of in vitro-differentiated
Th1 cells from Fasfl/flCd19-Cre mice. Consistent with these
results and those shown in Figure S4C, purified T cells, from
Fasfl/flCd19-Cre mice, that were cultured in IL-10 showed
more pSTAT3 in the nuclear fraction compared to controls
(Figure S5B). These data suggest that IL-10 triggers STAT3-me-
diated signaling in the mutant Th1 cells that leads to a block in
IFN-g production. Thus, the elevated serum IL-10 apparent in
Fasfl/flCd19-Cre mice may help to terminate the inflammatory
response, consistent with a report that IL-10 cooperates with
FasL to terminate antigen-specific immune responses (Barreiro
et al., 2004).
Taken together, these results show that a deficiency of Fas in
B cells has profound effects on T cell signaling and function.
Lymphoproliferation Associated with B Cell-Specific
Fas Deficiency Initiates in the GC
The abnormalities displayed by the Fas-sufficient T cells in Fasfl/fl
Cd19-Cre mice suggested that these T cells are affected by their
interactions with the Fas-deficient B cells present in these mu-
tants. Fas is highly expressed in GC B cells (Hennino et al.,
2001), and the GC is a site where critical T cell-B cell interactions
occur. To understand the physiological role of Fas in GC B cells
and to pinpoint why Fasfl/flCd19-Cre mice fail to maintain lym-
phocyte homeostasis, we generated mutants in which Fas was
ablated only in GC B cells. We crossed Fasfl/fl mice with Ighg1-
Cre mice (Casola et al., 2006) and subsequently with lpr mice
on the MRL background (Vidal et al., 1998) to yield Fasfl/lpr
Ighg1-Cre mice on the F1 (C57BL/6 3 MRL) background.
Flow-cytometric analysis confirmed the efficient deletion of the
Fas gene in GC B cells (PNAhiCD38lo) of our Fasfl/lprIghg1-Cre
mice (Figure 4A, right). The Fas gene was not deleted in
T cells, follicular B cells (FB), or marginal zone B cells (MZ) of
the mutant (Figure 4A, bottom left).
Like Fasfl/flCd19-Cre mice, Fasfl/lprIghg1-Cre mice showed
a defect in lymphocyte homeostasis as evidenced by their en-
larged spleens and LNs (Figure 4B and data not shown). Com-
pared to controls, the total lymphocyte number in the spleen of
8-month-old Fasfl/lprIghg1-Cre mice was increased by approxi-
mately 2-fold and both the B cell and T cell compartments had
expanded (Figure 4C). The increase of these cell numbers was
all statistically significant (p < 0.005). H&E staining of spleen sec-
tions from control Fasfl/lpr mice showed well-defined red pulp
and white pulp (Figure 4D, top left), whereas the Fasfl/lprIghg1-
Cre spleen exhibited disrupted architecture with no clear bound-
ary between the red and white pulp (Figure 4D, top right). Higher
magnification of these spleen sections revealed that cells from
the Fasfl/lprIghg1-Cre spleen were larger and had more abundant
cytoplasm (Figure 4D, bottom). The abnormal spleen architec-
ture in Fasfl/lprIghg1-Cre mice was also virtually identical to that
in Fasfl/flCd19-Cre mice (Figure 2D). Although the Fasfl/lprIghg1-
Cre mice were on the F1 (C57BL/6 3 MRL) background, their
phenotype was almost identical to that of Fasfl/flCd19-Cre mice
on a C57BL/6 background, with respect to development of
splenomegaly and lymphoadenopathy characterized by both
B cell and T cell expansion, distorted lymphoid-organ architec-
ture, and increased GC B cell numbers. Thus, ablation of Fas
Immunity
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disorder observed in Fasfl/flCd19-Cre mice.
We hypothesized that it was the loss of Fas-mediated apopto-
sis that initiated the immune disorder in GC B cells. In support of
this idea, although the percentage of GC B cells in the spleen
of an unimmunized Fasfl/lprIghg1-Cre mouse was similar to that
in controls (Figure 4E, top left), the percentage of GC B cells in
the mesenteric LN (mLN) of the mutant was increased by ap-
proximately 2-fold (Figure 4E, top right). When we immunized
mutant and control mice with sheep red blood cells (SRBCs;
a Td antigen), the proportion of GC B cells in the spleen and
mLN of control mice returned to baseline by 30 days postimmu-
Figure 4. Ablation of Fas in GC B Cells Re-
produces the Lymphoproliferative Disorder
in Fasfl/flCd19-Cre Mice
(A) Confirmation of Fas deletion in GC B cells. The
top portion shows flow-cytometric analysis of GC
B cells (PNAhiCD38lo) among gated CD19+ B cells
of Fasfl/lpr and Fasfl/lprIghg1-Cre mice. Numbers
are the percentage of GC B cells among total
B cells. The bottom-right portion shows the ab-
sence of Fas expression in GC B cells from mLN
of Fasfl/lprIghg1-Cre mice. The bottom-left portion
shows a Southern blot of T cells (T), follicular
B cells (FB), and marginal zone B cells (MZ) from
Fasfl/+Ighg1-Cre mice confirming the absence of
Cre-mediated recombination in cells other than
GC B cells.
(B) Increased weight of spleens from 3.5- and
8-month-old Fasfl/lpr and Fasfl/lprIghg1-Cre mice.
Each symbol represents an individual mouse.
(C) Increased absolute numbers of total lympho-
cytes and B and T cells in spleens of 8-month-old
Fasfl/lpr and Fasfl/lprIghg1-Cre mice. Results shown
represent the mean ± SD (n = 3/genotype).
(D) Disrupted splenic architecture. We stained
spleen sections from 8-month-old Fasfl/lpr (left)
and Fasfl/lprIghg1-Cre (right) mice with H&E to re-
veal the splenic architecture. Scale bars apply to
control and mutant samples in a pair.
(E) Accumulation of GC B cells. Representative
flow-cytometric analyses of GC B cells (PNAhi
CD38lo) within gated B cells in spleen (SP) and
mLN of 3- to 3.5-month-old Fasfl/lpr and Fasfl/lpr
Ighg1-Cre mice before (no imm) and 30 days after
immunization with SRBC.
(F) Accumulation of GC B cells in Fasfl/flCd19-Cre
mice. Representative flow cytometric analyses of
GC B cells among B220+ B cells in spleen (SP)
and mLN of unimmunized Fasfl/fl and Fasfl/flCd19-
Cre mice. Numbers in (F) and (G) are the percent-
age of GC B cells (PNAhiCD38lo) among gated
B cells.
nization (Figure 4E, bottom and data not
shown). In contrast, Fasfl/lprIghg1-Cre
mice immunized with SRBCs exhibited
a 3-5-fold increase in GC B cells over
controls and maintained this increase un-
til at least day 30 postimmunization. Inter-
estingly, unimmunized aged Fasfl/flCd19-
Cre mice showed a 2- to 4-fold increase
over controls in the number of spontaneous GCs present in the
lymphoid organs (Figure 4F). Taken together, these data suggest
that the immune disorder resulting from B cell-specific Fas defi-
ciency initiates in the GC.
The Lymphoproliferative Disorder in Fasfl/flCd19-Cre
Mice Is T Cell Dependent
GC formation is known to be critically dependent on T cell-B cell
interaction (Kalia et al., 2006). To test whether the immune disor-
der in Fasfl/flCd19-Cre mice was T cell-dependent, we removed
the T cells from these mutants by crossing Fasfl/flCd19-Cre mice
with Tcrb/ mice in which T cell development is blocked in theImmunity 29, 615–627, October 17, 2008 ª2008 Elsevier Inc. 621
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Fasfl/flCd19-CreTcrb/ mice lack T cells and have Fas-deficient B cells. B cells from Fasfl/fl, Fasfl/flCd19-Cre, and Fasfl/flCd19-CreTcrb/ mice were examined
for (A) MHC class II expression as in Figure 2B; (B) BrdU incorporation as in Figure 2C; and (C) B cell cellularity in the LN as in Figure 2A. The mean cellularity ± SD
is shown (n = 3–9 mice/genotype).
(D) H&E stained sections of spleen and liver from mice of the indicated genotypes. Scale bars apply to an entire row.thymus as a result of the absence of the TCRb chain (Mombaerts
et al., 1992). The resulting Fasfl/flCd19-CreTcrb/ mice possess
normal numbers of Fas-deficient B cells but show only a few
CD4+ and CD8+ T cells in the peripheral lymphoid organs
(Figure S6A). Strikingly, the upregulated MHC class II present
on Fasfl/flCd19-Cre B cells had returned to normal on Fasfl/fl
Cd19-CreTcrb/ B cells (Figure 5A). Furthermore, the propor-622 Immunity 29, 615–627, October 17, 2008 ª2008 Elsevier Inc.tion of BrdU+ cells in the B cell compartment dropped from
28.6% in Fasfl/flCd19-Cre mice to 10.6% in Fasfl/flCd19-
CreTcrb/ mice, a level comparable to that in Fasfl/fl controls
(Figure 5B). As a consequence, the size of the Fasfl/flCd19-
CreTcrb/ spleen was close to normal (data not shown). The
total B cell cellularity in LNs of Fasfl/flCd19-CreTcrb/ mice
was also similar to that of Fasfl/fl controls (p = 0.47), whereas
Immunity
Fas/ B Cells Cause Fatal Lymphoproliferationthe LNs of Fasfl/flCd19-Cre mice had approximately 5-fold more
B cells than controls (p < 0.005) (Figure 5C). In the spleen, H&E
staining revealed that the disrupted architecture prominent in
Fasfl/flCd19-Cre mice (Figure 5Dii) was restored to normal in
Fasfl/flCd19-CreTcrb/ mice (Figure 5Diii). Finally, the lympho-
cyte infiltration in Fasfl/flCd19-Cre liver (Figure 5Dv) was absent
in Fasfl/flCd19-CreTcrb/ liver (Figure 5Dvi). Thus, T cells are re-
quired for the B cell lymphoproliferation observed in Fasfl/flCd19-
Cre mice. On the basis of these results and our finding that mice
lacking Fas specifically in GC B cells reproduce the phenotype of
Fasfl/flCd19-Cre mice, we theorize that interactions between the
Fas-sufficient T cells and Fas-deficient B cells within the GCs of
these mutants drive the immune disorder.
Expansion of Memory B Cell Compartment
in Fasfl/flCd19-Cre Mice
The defect in the negative selection of GC B cells in the absence
of Fas (Figure 4) prompted us to investigate whether the plasma
cells and memory B cells that differentiated from these GC B cells
exhibited abnormalities as well. The number of CD138+ (synde-
can-1) cells in the spleen and LNs of aged Fasfl/flCd19-Cre mice
was greater by 2- to 3-fold than controls (data not shown).
When we examined the B220+IgM–IgD– B cell population (which
contains memory B cells and GC B cells), we found an approxi-
mately 3-fold increase in the frequency and a 10-fold increase
in the absolute numbers of these cells in the spleens of Fasfl/fl
Cd19-Cre mice compared to in controls (Figure 6A, middle; p <
0.005). Consistent with this observation, the proportion and total
numbers of splenic B220+IgG1+ B cells that were IgM–IgD– were
increased approximately 10-fold and 30-fold, respectively, over
controls (Figure 6B, top, middle; p < 0.05). Approximately 98%
of B220+IgG1+ B cells in the mutant (90% in controls) were
CD38+ cells (data not shown), indicating that these cells were pre-
dominantly memory B cells rather than GC B cells (Takahashi
et al., 2001). WT memory B cells typically are larger than naive
B cells and show a body-wide circulation pattern (Liu et al.,
1995) (Linton and Klinman, 1992). The B220+IgG1+ memory
B cells of Fasfl/fl and Fasfl/flCd19-Cre mice were indeed larger
than naive B cells and substantial numbers of them were found
both in the circulation and mLN (data not shown).
CD28-CD80 Interaction Is Required for the
Lymphoproliferative Disorder in Fasfl/flCd19-Cre Mice
WT memory B cells are potent activators of T cells because of
their enhanced upregulation of CD80 and CD86 (Liu et al.,
1995). Memory B cells from Fasfl/flCd19-Cre mice showed upre-
gulated CD80 but control amounts of CD86 (Figure 6B, bottom).
To investigate whether CD28-CD80 signaling was important for
the accumulation of memory B cells and the abnormal T and
B cell phenotypes of Fasfl/flCd19-Cre mice, we crossed these
mutants with Cd28/ mice (Suh et al., 2004) to generate Fasfl/fl
Cd19-CreCd28/ mice. Analysis by flow cytometry confirmed
that CD28 expression was absent on T cells of the compound
mutants (Figure S6B). The expansion of the B220+IgM–IgD–
B cell population observed in Fasfl/flCd19-Cre mice did not occur
when CD28 was deleted (Figure 6A, right), and the percentage of
B220+IgG1+ B cells (of which approximately 90% were CD38+) in
Fasfl/flCd19-CreCd28/mice was reduced to 30% compared to
that in Fasfl/fl controls (Figure 6B, top right). Thus, the accumula-tion of IgG1+ memory B cells in Fasfl/flCd19-Cre mice is CD28
dependent, and the reduction of IgG1+ memory B cells in
Fasfl/flCd19-CreCd28/ mice is likely to be due to the impair-
ment of GC formation that occurs in the absence of CD28
(Ferguson et al., 1996). The lack of CD28 in these mutants also
disrupted the excessive upregulation of ICOS and MHC class II
observed in Fasfl/flCd19-Cre B cells (Figure 6C). Thus, the abnor-
mal activation of both T and B cells in Fasfl/flCd19-Cre mice
depends on CD28.
The hyporesponsiveness to IFN-g of T cells from Fasfl/flCd19-
Cre mice was restored to normal in the absence of CD28, as
evidenced by the reappearance of control amounts of STAT1
phosphorylation in T cells of Fasfl/flCd19-CreCd28/ mice
(Figure 6D). Analysis of in vivo BrdU incorporation showed that
CD28 ablation not only prevented hyperproliferation but also re-
duced the proliferation of CD4+ and CD8+ T cells and B220+
B cells to 30%–50% compared to in Fasfl/fl controls (Figure 6E).
The enlarged spleen present in Fasfl/flCd19-Cre mice became
normal in size in nine of ten Fasfl/flCd19-CreCd28/ mice, and
none of the compound mutants had enlarged LNs (data not
shown). Indeed, LN cellularity in Fasfl/flCd19-CreCd28/ mice
was lower than in the Fasfl/fl controls (15.4 ± 8.6 3 106 versus
22.6 ± 8.64 3 106), and this reduction held true when B and
T cell numbers were examined separately (Figure 6F). Lastly, lym-
phoid-organ architecture was restored to normal and lymphocyte
infiltration in the liver was prevented in Fasfl/flCd19-CreCd28/
mice (Figure S7).
These results reinforce the conclusion drawn from our analy-
ses of Fasfl/lprCg1Cre and Fasfl/flCd19-CreTcrb/ mice: that
the lymphoproliferative disorder in B cell-specific Fas KO mice
initiates in the GC where negative selection of GC B cells is im-
paired in the absence of Fas-mediated apoptosis (Takahashi
et al., 2001). Memory B cells that would otherwise have been de-
leted instead expand and interact with CD4+ Th cells, resulting in
T cell expansion that is amplified by a positive-feedback loop op-
erating through the CD28-CD80 pathway. These accumulating
lymphocytes infiltrate the organs and induce a potentially fatal in-
flammatory cytokine storm.
DISCUSSION
Our Fasfl/flCd19-Cre and Fasfl/lprIghg1-Cre mice are unique in
that Fas is deleted only in B lineage cells and all other cells are
Fas sufficient. The Fas-deficient B cells in both of our mutant
strains were activated and hyperproliferative. Unexpectedly,
the Fas-sufficient T cells in Fasfl/flCd19-Cre mice were also acti-
vated and hyperproliferative. Our analyses suggest that Fas ex-
pression by B cells has an important role in the maintenance of
T cell homeostasis via T cell-B cell interaction and that this inter-
action occurs in the GC. On the basis of the literature and our
in vivo analyses of Fasfl/lprIghg1-Cre and Fasfl/flCd19-Cre mice,
we propose the following model of how Fas-mediated negative
selection of GC and memory B cells regulates T and B lympho-
cyte homeostasis. Antigen (Ag)-activated B cells interact with
Ag-activated Th cells and then initiate GC formation. Some prog-
eny GC B cells through somatic hypermutation may express
BCRs with improved binding affinity for the cognate Ag (high
affinity), whereas others will bear BCRs with suboptimal affinity
for the Ag or a BCR that recognizes self-Ag (autoreactive). WithImmunity 29, 615–627, October 17, 2008 ª2008 Elsevier Inc. 623
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Fasfl/flCd19-CreCd28/ mice lack CD28 in all cells and Fas in B cells only. Fasfl/fl, Fasfl/flCd19-Cre, and Fasfl/flCd19-CreCd28/ mice were examined for (A)
percentage of B220+IgM–IgD– B cells. Mean numbers ± SD of B220+IgM–IgD– B cells in spleens of Fasfl/fl, Fasfl/flCd19-Cre, and Fasfl/flCd19-CreCd28/ mice
(n = 3–4/genotype) were 7.6 ± 1.78 3 105, 37.8 ± 5.1 3 105 and 4.8 ± 0.96 3 105, respectively. Fasfl/fl, Fasfl/flCd19-Cre, and Fasfl/flCd19-CreCd28/ mice
were examined for (B) percentage of B220+IgG1+ memory B cells (top) and CD80 and CD86 expression (bottom). Mean numbers ± SD of B220+IgG1+ memory
B cells in spleens of Fasfl/fl, Fasfl/flCd19-Cre and Fasfl/flCd19-CreCd28/ mice (n = 3–4/genotype) were 2.9 ± 1.33 104, 85.2 ± 58.63 104 and 1.73 ± 1.173 104,
respectively. (C) shows the expression of the indicated markers on T and B cells as in Figure 2B; (D) shows STAT1 phosphorylation in IFN-g-stimulated T cells as in
Figure S4B; (E) shows BrdU incorporation as in Figure 2C; and (F) shows LN cellularity (right) as in Figure 2A; the mean cellularity ± SD is shown (n = 3–7 mice/
genotype). *(*)p < 0.05 for Fasfl/fl versus Fasfl/flCd19-Cre mice but p < 0.005 for Fasfl/flCd19-Cre versus Fasfl/flCd19-CreCd28/ mice. Mice wereR11 months old
(A, B, C, E, and F) or 5 to 6 months old (D).the help of the activated Th cells, the high affinity GC B cells are
positively selected to differentiate into either plasma cells or
memory B cells. In the case of Fas-competent B cells, B cells
with suboptimal affinity or autoreactivity are eliminated through
Fas-dependent apoptosis and lymphocyte homeostasis is main-
tained. In the absence of functional Fas, GC B cells expressing
BCRs with suboptimal affinity or autoreactivity do not undergo624 Immunity 29, 615–627, October 17, 2008 ª2008 Elsevier Inc.apoptosis and are able to differentiate into plasma cells or mem-
ory B cells. Memory B cells (including those derived from naive B
cells with suboptimal affinity) are potent APCs, and the greatly in-
creased numbers of these cells in turn activate large numbers of
Th cells, including rare autoreactive Th cells. The lymphoprolifer-
ative disorder is thus initiated. Upon interaction with an activated
Th cell, a memory B cell further upregulates CD80 and becomes
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mediated costimulation from these memory B cells undergo
rapid expansion and return to the GC to select more suboptimal
affinity and autoreactive GC B cells into the memory B cell pool.
This positive-feedback loop drives the proliferation of both T and
B cells such that a fatal loss of homeostasis occurs. We recog-
nize that further investigation is needed to clarify the extent to
which interference with GC formation contributes to the preven-
tion of lymphoproliferation in Fasfl/flCd19-Cre mice upon removal
of T cells or CD28. However, the recapitulation of the disease
phenotype in Fasfl/lprIghg1-Cre mice argues in favor of the inter-
pretation that GC and post-GC B cells play a dominant patho-
genic role.
Most studies agree that Fas is highly expressed in GC B cells
and has an essential role in GC B cell apoptosis both in vitro
(Hennino et al., 2001) and in vivo (Takahashi et al., 2001). During
the GC reaction, antigen-activated B cells undergo somatic Ig-
gene hypermutation that may increase antibody affinity. How-
ever, some of these alterations may change antibody specificity
and/or result in the acquisition of autoreactivity (Hande et al.,
1998; Rajewsky, 1996). Several studies have demonstrated
that Fas-mediated apoptosis is essential for eliminating autor-
eactive B cells (Fukuyama et al., 2002; Rathmell et al., 1995;
William et al., 2002). When somatic hypermutation mistakenly in-
troduces deleterious alterations into the Fas gene in GC B cells
(Muschen et al., 2000), impaired Fas-mediated negative selec-
tion of GC B cells could potentially result in autoreactive B cell
generation as proposed by our model.
The ablation of T cells or CD28 in Fasfl/flCd19-Cre mice totally
abolished lymphocyte hyperproliferation and infiltration. In the
absence of T cells or CD28, B cell activation was also decreased
as judged by reductions in MHC class II expression and hyper-
proliferation and by the restoration of baseline B cell numbers.
Because CD4+ Th cells and their expression of CD28 are essen-
tial for GC formation (Kalia et al., 2006), and the lymphoprolifer-
ative disorder of Fasfl/flCd19-Cre mice initiates in the GC, the
disease was prevented in animals in which GC formation was
abolished by the genetic removal of T cells or CD28. These con-
siderations may partially explain why the Fas-deficient B cells
that resisted homeostatic control in the presence of T cells be-
came sensitive to such control when T cells or CD28 were ab-
sent. However, it is also possible that when T cell-B cell inter-
action and GC formation are disrupted, a Fas-independent
mechanism is able to eliminate excess Fas-deficient B cells
and restore B cell homeostasis. It may be that, like the survival
of WT B cells, the survival of Fas-deficient B cells is controlled
by BAFF in the local environment (Mackay et al., 2003), but this
remains to be investigated.
Lpr and Fasfl/flCd19-Cre mice both develop autoimmune lym-
phoproliferation but the peculiar DN T cells predominant in the
former are not present in the latter. In addition, although CD28
ablation in Fasfl/flCd19-Cre mice completely prevents the im-
mune disorder, CD28 ablation in lpr mice blocks only the devel-
opment of autoimmune symptoms; lymphoproliferation is in fact
accelerated in the spleen of these mutants (Tada et al., 1999).
Similarly, ICOS ablation in lprmice that should abolish GC forma-
tion fails to prevent splenomegaly and lymphadenopathy (Zeller
et al., 2006). Thus, the CD28-B7 and ICOS-ICOSL pathways do
not appear to play major roles in the expansion of DN T cells in lprmice. In contrast, CD28-CD80 interaction either between acti-
vated B cells and CD4+ Th cells during initial GC formation or be-
tween memory B cells and CD4+ Th cells in an established GC is
critical for the lymphoproliferative disorder observed in Fasfl/fl
Cd19-Cre mice.
Fas-mediated apoptosis is involved in the negative selection
of autoreactive B cells in the bone marrow; such a selection es-
tablishes central B cell tolerance (Lamoureux et al., 2007) (Sea-
gal et al., 2003). In this study, we have demonstrated that the
Fas-mediated apoptosis that is in GC B cells and that establishes
peripheral tolerance also functions as an essential checkpoint
governing T cell and memory B cell homeostasis. Defects such
as Fas deficiency that result in the unintended positive selection
of ‘‘inappropriate’’ memory B cells can lead to amplification of
the Th cell population and highly destructive lymphoproliferation.
EXPERIMENTAL PROCEDURES
Mice
Fasfl/fl mice and Fasfl/flCd19-Cre mice were as described (Hao et al., 2004). To
delete Fas specifically in GC B cells, we bred Fasfl/fl mice with Ighg1-Cre mice
(Casola et al., 2006). We backcrossed the resulting Fasfl/flIghg1-Cre mice for
eight generations to C57BL/6 mice and then bred them to lpr mice on the
MRL background (Vidal et al., 1998) to yield Fasfl/lprIghg1-Cre mice on the
F1 (C57BL/6 3 MRL) background. T cells were deleted in Fasfl/flCd19-Cre
mice by crossing to Tcrb/ mice (Mombaerts et al., 1992). The resulting
Fasfl/+Tcrb+/ F1 mice, with or without Cd19-Cre, were intercrossed for gener-
ation of Fasfl/flCd19-CreTcrb/ compound mutant mice. Cd28 was deleted in
Fasfl/flCd19-Cre mice by crossing to Cd28/ mice (Suh et al., 2004). The re-
sulting Fasfl/+Cd28+/ F1 mice, with or without Cd19-Cre, were intercrossed
for generation of Fasfl/flCd19-CreCd28/ compound mutant mice. Fasfl/fl
Cd19-Cre, Fasfl/flCd19-CreTcrb/ and Fasfl/+Cd19-CreCd28+/ strains were
all backcrossed to C57BL/6 for more than eight generations. Because Cre ex-
pression can be toxic to cells (Schmidt-Supprian and Rajewsky, 2007), we
included Fasfl/+Cd19-Cre, Fasfl/+Ighg1-Cre, Faslpr/+Cg1Cre, Fasfl/+Cd19-
CreTcrb/, and/or Fasfl/+Cd19-CreCd28/ mice in all initial analyses of the
corresponding mutants. These control mice were phenotypically indistinguish-
able from the control animals used for the analyses presented in this paper, as
judged by cellularity and size of spleen and LNs. ‘‘Aged’’ mice were R6
months old unless otherwise specified. All animal experiments were approved
by the University Health Network Animal Care Committee.
Flow Cytometry
Spleen and LN cells (13 106) were stained with antibodies recognizing the fol-
lowing: IgM (II/41), IgD(11-26c.2a), I-Ab (AF6-120.1), IgG1 (X56), NK cells (DX5),
Pan-TER-119 (TCR-119), Thy1.2 (Cfo 1), CD3 (145-2C-11), CD4 (Gk1.5 or
RM4.5), CD8 (53-6.7), CD11b (M1/70), CD11c (HL3), CD16/CD32 (2.4G2),
CD19 (1D3), CD21 (7G6), CD23 (B3B4), CD25 (PC61), CD28 (37.51), CD38
(90), CD40 (3/23), CD43 (S7), CD45R/B220 (RA3-6B2), CD69 (H1.2F3), CD80
(16-10A1), CD86 (GL1), CD95 (Jo-2), CD152 (CTLA-4; UC10-4F10-11),
CD154 (CD40 ligand; MR1), CD275 (ICOSL; HK5.3), and CD278 (ICOS;
7E.17G9). All antibodies were from BD Biosciences or eBioscience. Data
were acquired by either BD FACSCalibur or BD FACSCanto flow cytometer
and analyzed with either BD CellQuest or the FlowJo analysis program (Tree
Star).
BrdU Incorporation
Mice were fed BrdU-containing drinking water (1mg/ml) for 3 days. Spleen and
LN cells were immunostained as described above. BrdU was detected with
a BrdU-Flow kit (BD Biosciences).
STAT Phosphorylation
Cultured LNcells (13106)were stimulated for15minwith either IFN-g (100 U/ml;
Biosource) or mrIL-10 (100 ng/ml; Biosource), fixed with 1.6% paraformalde-
hyde, and incubated for 30 min at room temperature. After one wash in PBS,Immunity 29, 615–627, October 17, 2008 ª2008 Elsevier Inc. 625
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for 30 min. Washed cells were incubated with antibodies recognizing B220
(RA3-6B2), CD4 (RM4.5), CD8 (53-6.7), phospho-STAT1 (pY701), or phospho-
STAT-3 (pY705) (all from BD Biosciences) and then analyzed by flow cytometry.
Immunohistology
Mouse organs were fixed either in 10% formalin or 4% PFA at 4C for 20–24 hr,
embedded in paraffin, sectioned, and stained with H&E according to standard
procedures. Immunostaining of T and B cells in lymphoid and nonlymphoid or-
gans was as previously described (Hao et al., 2004) with slight modifications.
Statistical Analyses
The Student’s t test was employed for statistical analyses. Values are ex-
pressed as the mean ± SD. A p value of <0.05 was considered statistically
significant. *p < 0.05; **p < 0.005.
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Results, Supplemental Experimen-
tal Procedures, and seven figures and can be found with this article online at
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